Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (291-300 of 308) with videos related to

Pageof 31
Sort By:
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Nature|October 31, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastomaHiromichi Suzuki, Sachin A Kumar, Shimin Shuai, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 31

Showing results (291-300 of 308) with videos related to

Sort By:
Pageof 31
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Acta Neuropathologica|August 19, 2021
Subgroup and subtype-specific outcomes in adult medulloblastomaHallie Coltin, Lakshmikirupa Sundaresan, Kyle S Smith, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Nature|October 31, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastomaHiromichi Suzuki, Sachin A Kumar, Shimin Shuai, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 31